Amrutanjan Health Care share news, announcements and annual reports
NSE: AMRUTANJANBSE: 590006Pharmaceuticals & BiotechnologySmall Cap
Amrutanjan Health Care Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary
Last close ₹496.65up ₹3.45 (0.70%)BSE ₹496.85
Share price at the NSE close on 30 Oct 2026. Previous close ₹493.20.
30 Oct: open ₹488.30, high ₹509.00, low ₹488.30
52-week range of traded prices to 30 Oct 2026
₹476.50Low, 16 Sep 2026₹754.00High, 30 Oct 2025
- Next results date: the board meets on 3 Nov 2026 to consider: financial results and dividend. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,436 Cr1,245th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 26.60
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 22.14
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.88
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.99%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.5%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 18.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 18.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 29,73759.9% delivered
Amrutanjan Health Care share news and announcements
504 announcements, routine notices left out, newest first. Page 10 of 11.
Aug 2012
31 Aug · Meeting
Register of Members and Share Transfer Books of the Company shall remain closed from 24th September 2012 to 27th September 2012 (inclusive of both days) for the purpose of declaration of Dividend at the 75th Annual General Meeting of the Company to be held on 27th September 2012. (Source MSE)6 Aug · Corporate action
Board of Directors, at its meeting held on 6th August 2012, had inter-alia, considered and approved the sub-division of existing equity share of nominal value of Rs. 10/- each fully up into two equity shares of nominal value of Rs. 5/- each fully paid up. (Source MSE)
Jul 2012
27 Jul · Board meeting
To consider inter-alia the Un-audited Financial Results of the Company for the quarter ended 30th June 2012. (Source MSE)
May 2012
30 May · Dividend
Board of Directors at its meeting held on 30th May 2012, has recommended a Final Dividend of Rs. 10/- per share (of face value Rs.10/- each) for the Financial year 31st March 2012. (Source MSE)22 May · Board meeting
Inter-alia to consider the Audited Financial Results for the quarter/year ended 31st March 2012 along with the statement of assets and liabilities for the year ended 31st March 2012. (Source MSE)
Feb 2012
14 Feb · Updates
Record date for reckoning the members who will be entitled to receive the Interim Dividend of Rs. 5/- per share (50%) on the equity shares for the year 2011-12 has been fixed as 24th February, 2012. (Source MSE)13 Feb · Board meeting
Board of Directors of the Company at their meeting held on 13th February, 2012 , inter -alia, considered and approved the following items: (1) Declared Interim Dividend of Rs. 5/- per share for the year 2011-2012. ( 50% on face value of Rs. 10/-) on the Equity Shares of the Company; (2) Mr. S. Sambhu Prasad, Managing Director of the Company , has been redesignated as Chairman & Managing Director of the Company with effect from February 13, 2012; and (3) Merger of Wholly Owned Subsidiary M/s. Siva's Soft Drinks Private Limited with the Company. (Source MSE)3 Feb · Board meeting
Inter-alia to consider the following: (1) Un-audited Financial Results for the quarter ended 31st December, 2011 and (2) Declaration of Interim Dividend for the nine months ended 31st December 2011. (Source MSE)
Nov 2011
Oct 2011
28 Oct · Board meeting
To consider and take on record, inter-alia, the Un-audited Financial Results of the Company for the second quarter ended 30th September 2011 (Source MSE)24 Oct · Key Management Persons
Mrs. Hema Pasupatheeshwaran, Company Secretary and Compliance Officer, has resigned with effect from 6th October 2011. (Source MSE)
Sep 2011
5 Sep · Meeting
Register of Members and Share Transfer Books of the Company will remain closed from 14th September, 2011 to 19th September, 2011 (both days inclusive) in connection with the 74th Annual General Meeting to be held on 19th September, 2011 and the Company has further informed that the Final Dividend for the financial year 2010- 2011, after declaration at the AGM, will be paid on or after 19th September 2011, but within the statutory period of 7 days. (Source MSE)
Aug 2011
8 Aug · Updates
Board of Directors, at the meeting held on 8th August 2011, recommended a dividend of Rs.10/- per equity share of Rs.10/- each, which together with the already declared interim dividend, amounts Rs.15/- per equity share. (Source MSE)
Jul 2011
22 Jul · Board meeting
To consider and take on record, inter-alia, the Un-audited Financial Results of the Company for the first quarter ended 30th June, 2011. (Source MSE)19 Jul · Buyback
Offer for buyback of 1,06,937 fully paid up equity shares of Rs. 10/- each by the Company through a tender offer, at a price of Rs. 900/- per share, has been closed on July 18, 2011. (Source MSE)
May 2011
27 May · Buyback
Copy of the following, which were published in the news papers: (1) Public Announcement, in terms of Provisions of Regulation 8(1) of the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 1998, for the buy-back of Equity shares from the existing equity shareholders of the Company on a proportionate basis through "Tender Offer" and (2) Corrigendum to the Public Announcement (Source MSE)6 May · Buyback
Buy-back Committee of the Company, at its meeting held on 6th May 2011, fixed the buy-back price at Rs.900/- per equity share. (Source MSE)3 May · Buyback
Board of Directors of the Company, at its meeting held on 3rd May, 2011, resolved to buy-back equity shares of the Company under section 77A of the Companies Act, 1956 read with Securities and Exchange Board of India (Buy-back of Securities) Regulations, 1998. The Company has further informed that the said buy-back shall not exceed 10% of the paid-up share capital and free reserves through Tender Offer Method at a price to be determined by the Committee of Directors, Viz., Buy-back Committee at its meeting to be held at a later date. (Source MSE)
Apr 2011
20 Apr · Outcome of meeting
Proceedings held on 23rd March 2011 of the Result of the Postal Ballot conducted pursuant to Section 192A of the Companies Act, 1956 on the ordinary resolution for transfer by way of sale or otherwise the Pharmaessence Chemistry Services Division of the Company to a wholly owned subsidiary of the Company. (Source MSE)20 Apr · Board meeting
To consider and take on record, inter-alia, the Unaudited Financial Results of the Company for the fourth quarter ended 31st March, 2011. (Source MSE)20 Apr · Business
New business activity as follows:" In order to forward integrate from products to services, the Company has entered into a New Business activity viz. Pain Management. The Board of Directors of the Company has granted approval for the same. The objects clause of the Company was also revised with the approval of the shareholders through postal ballot, for this purpose. In furtherance of the said objects, the Company is shortly to open its first centre for specialized Pain Management in T. Nagar, Chennai, which would provide treatment from non-invasive to invasive interventions. More details on this can be obtained from the Company's website" (Source MSE)
Mar 2011
3 Mar · Business
Company has entered into an agreement with M/s. Siva's Soft Drink Private Limited, Chennai, to acquire their soft drink and fruit based beverages business along with the brand, 'Fruitnik' for a total consideration of Rs. 26.20 Crores. (Source MSE)
Feb 2011
22 Feb · Meeting
Copies of Postal Ballot Notice, for passing Ordinary resolution under Section 293(1)(a) of the Companies Act, 1956, authorising the Board of Directors of the Company to transfer / sell the 'Pharmaessense Chemistry Services' Division of the Company to a wholly owned subsidiary. Attachment follows (Source MSE)10 Feb · Updates
Record date for the payment of Interim Dividend of Rs.5/- per Equity share of Rs.10/- each of the Company (50 per cent) for the year 2010-11, made in the Announcement today shall read as 22nd February 2011 instead of 22nd February 2001. (Source MSE)10 Feb · Board meeting
Company has fixed 22nd February 2001 as the Record Date for reckoning the members who will be entitled to receive the Interim Dividend for the year 2010-11. (Source MSE)10 Feb · Board meeting
Board of Directors at its meeting held on 10th February, 2011 have declared an Interim Dividend of Rs. 5/- per share ( 50 per cent ) on the Equity Share Capital of Rs. 3.03 Crores for the financial year 2010-11. The Company has further informed that the Interim Dividend shall be paid on or after 28th February 2011, but within the statutory period of 30 days. (Source MSE)
Jan 2011
31 Jan · Board meeting
To consider and take on record, inter-alia, the Unaudited Financial Results of the company for the third quarter ended December 31, 2010. (Source MSE)13 Jan · Board meeting
To consider new business proposals. (Source MSE)7 Jan · Meeting
Shareholders of the Company have accorded approval through Postal Ballot on 05.01.2011 for i) dividing the objects clause as Main Objects; Objects incidental or Ancillary to the attainment of the Main Objects; and Other Objects pursuant to the Section 13 of the Companies Act, 1956 and amendment of the Objects Clause of the Memorandum of Association of the Company pursuant to the Section 17 of the Companies Act, 1956 and ii) Special Resolution pursuant to Section 149(2A) of the Companies Act, 1956 for commencement of new business activities. Attachment follows (Source MSE)
Dec 2010
3 Dec · Disclosure
Disclosure for the acquisition of 500 Equity shares of the Company by Ms. S. Rajeswari, in terms of Regulation 7(3) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997. Attachment follows (Source MSE)3 Dec · Disclosure
Disclosure for the acquisition of 500 Equity shares of the Company by Ms. S. Rajeswari, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 1992. Attachement follows. (Source MSE)
Nov 2010
16 Nov · Change in Company Secretary
Consequent upon the resignation of Mr. N.S.Mohan, Company Secretary, Ms. Hema Pasupatheeswaran has been appointed as the Secretary of the Company with effect from 12.11.2010 and she shall be the Compliance Officer of the Company. (Source MSE)2 Nov · Board meeting
To consider and take on record, inter-alia, the Unaudited Financial Results of the Company for the second quarter ended 30th September, 2010. (Source MSE)
Oct 2010
Sep 2010
13 Sep · Management
Mr. N.S. Mohan, Company Secretary, has resigned from the services of the Company with effect from 9th September 2010. (Source MSE)
Aug 2010
Jul 2010
29 Jul · Board meeting
To consider and take on record, inter-alia, the Un-audited Financial Results of the Company for the first quarter ended 30th June, 2010. (Source MSE)22 Jul · Meeting
Register of Members and Share Transfer Books of the Company will remain closed from 17th August 2010 to 25th August 2010 (both days inclusive) in connection with the 73rd Annual General Meeting of the Company scheduled to be held on 25th August 2010. The Company has also informed that the Final Dividend for the Financial Year 2009-10, after declration at the Annual General Meeting, will be paid on or after 25th August 2010, but within the statutory period of 30 days. (Source MSE)15 Jul · Buyback
Board of Directors of the Company at its meeting held on 14th July 2010 resolved to withdraw the Buy-back Offer of equity shares of the Company, in view of the fact that the market prices of the shares gave gone up over and above the buy-back offer price of Rs.550/- per share. (Source MSE)15 Jul · Restructuring of Business
Board of Directors of the Company at its meeting held on 14th July 2010, has, in principle, approved the restructuring of the Company's OTC and Pharma Business. The Company further informed that the Board has resolved to incorporate two wholly owned subsidiary companies for the above purpose. (Source MSE)15 Jul · Dividend
At the Board meeting held on 14th July 2010, it was resolved to recommend payment of Final Dividend of Rs.10/- per share (100%) on the Equity share capital, for the year ended 31st March 2010 (Source MSE)6 Jul · Board meeting
To consider the Audited Financial Results of the Company for the year ended 31st March 2010 and also to recommend final dividend on the equity shares of the Company, for the financial year 2009-10. (Source MSE)
May 2010
5 May · Board meeting
To consider and take on record, inter alia, the unaudited financial results for the fourth quarter ended March 31, 2010 (Source MSE)
Apr 2010
5 Apr · News Verification
News Verification : The media had reports on April 3, 2010 that Emami Limited may acquire shares of Amrutanjan Health Care Limited. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Amrutanjan Health Care Limited has vide its letter inter-alia stated, "We would like to reply that the said news item is false and without basis. The promoters of the company have no intention to sell out and the promoters do not forsesee any reason to dilute their stake and exit from the company." (Source MSE)